TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that pursuant to an agreement entered in January 2015, Orchid Pharma, Inc. has engaged TruPharma to manage the day-to-day sales & marketing of its existing portfolio of approximately fifteen FDA-approved ANDA products, as well as a pipeline of pending ANDA products. TruPharma will support its existing US operation with the sales, marketing and distribution of these products on the Orchid label.